Detection of CKD in the Elderly When a decreased eGFR is CKD
(
00:00
/27:56)
Outline
1. DETECTION OF CKD IN THE
2. It all depends.
3. tt depends on-
4, CURRENT DEFINITION OF G
5. Chronic Kidney Disease
6. The Current Classificat
7. Thresholds of eGFR for
8. Consequences of an eGFR
9. CKD Prevalence-USA: NHA
10. CKD Prevalence- Global
11. CKD-NHANES Prevalence
12. CKD- Characteristics o
13. eGFR Equations: Perfor
14. eGFR by MDRD or CKD-EP
15. eGFR and Mortality/CD
16. CKD-CD: Adjusted HR fo
17. All-Cause Mortality an
18. CKD Stage 3 Risk of Ca
19. CKD and Risk of ESRD o
20. CKD and Risk or ESRD o
21. In the elderly with 'S
22. Expected Change in GFR
23. Expected Rate of Decli
24. Cer in Aging: Cross-se
25. eGFR (MDRD) in 'Health
26. lothalamate Clearance
27. Longitudinal Study of
28. Distribution of Slopes
29. Distribution of Slopes
30. Longitudinal Studies o
31. Reasons for the Discre
32. Reasons
33. eGFR and Age- With and
34. The decline in GFR may
35. The Major Issue is wha
36. A New Risk-Based Class
37.
38. Distribution of Classi
39. Alouminuria (UACR) as
40. Hazard Ratios for 2Scr
41. UACR is a “bipolar�
42. CONCLUSIONS- I: When a
43. CONCLUSIONS- II: When
44, CONCLUSIONS- Ill: When
45. THANK YOU
Thumbnails
1. DETECTION OF CKD IN THE
2. It all depends.
3. tt depends on-
4, CURRENT DEFINITION OF G
5. Chronic Kidney Disease
6. The Current Classificat
7. Thresholds of eGFR for
8. Consequences of an eGFR
9. CKD Prevalence-USA: NHA
10. CKD Prevalence- Global
11. CKD-NHANES Prevalence
12. CKD- Characteristics o
13. eGFR Equations: Perfor
14. eGFR by MDRD or CKD-EP
15. eGFR and Mortality/CD
16. CKD-CD: Adjusted HR fo
17. All-Cause Mortality an
18. CKD Stage 3 Risk of Ca
19. CKD and Risk of ESRD o
20. CKD and Risk or ESRD o
21. In the elderly with 'S
22. Expected Change in GFR
23. Expected Rate of Decli
24. Cer in Aging: Cross-se
25. eGFR (MDRD) in 'Health
26. lothalamate Clearance
27. Longitudinal Study of
28. Distribution of Slopes
29. Distribution of Slopes
30. Longitudinal Studies o
31. Reasons for the Discre
32. Reasons
33. eGFR and Age- With and
34. The decline in GFR may
35. The Major Issue is wha
36. A New Risk-Based Class
37.
38. Distribution of Classi
39. Alouminuria (UACR) as
40. Hazard Ratios for 2Scr
41. UACR is a “bipolar�
42. CONCLUSIONS- I: When a
43. CONCLUSIONS- II: When
44, CONCLUSIONS- Ill: When
45. THANK YOU
Notes
MAU: Summary
Time: 01 min 17 sec
Search
Search in
Slide text
Slide notes
Slide titles
References
Slide
01
/45
00:00
/ 27:56
